Desmin-related myofibrillar myopathy

Jump to navigation Jump to search
Desmin-related myofibrillar myopathy
Classification and external resources
OMIM 601419

WikiDoc Resources for Desmin-related myofibrillar myopathy

Articles

Most recent articles on Desmin-related myofibrillar myopathy

Most cited articles on Desmin-related myofibrillar myopathy

Review articles on Desmin-related myofibrillar myopathy

Articles on Desmin-related myofibrillar myopathy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Desmin-related myofibrillar myopathy

Images of Desmin-related myofibrillar myopathy

Photos of Desmin-related myofibrillar myopathy

Podcasts & MP3s on Desmin-related myofibrillar myopathy

Videos on Desmin-related myofibrillar myopathy

Evidence Based Medicine

Cochrane Collaboration on Desmin-related myofibrillar myopathy

Bandolier on Desmin-related myofibrillar myopathy

TRIP on Desmin-related myofibrillar myopathy

Clinical Trials

Ongoing Trials on Desmin-related myofibrillar myopathy at Clinical Trials.gov

Trial results on Desmin-related myofibrillar myopathy

Clinical Trials on Desmin-related myofibrillar myopathy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Desmin-related myofibrillar myopathy

NICE Guidance on Desmin-related myofibrillar myopathy

NHS PRODIGY Guidance

FDA on Desmin-related myofibrillar myopathy

CDC on Desmin-related myofibrillar myopathy

Books

Books on Desmin-related myofibrillar myopathy

News

Desmin-related myofibrillar myopathy in the news

Be alerted to news on Desmin-related myofibrillar myopathy

News trends on Desmin-related myofibrillar myopathy

Commentary

Blogs on Desmin-related myofibrillar myopathy

Definitions

Definitions of Desmin-related myofibrillar myopathy

Patient Resources / Community

Patient resources on Desmin-related myofibrillar myopathy

Discussion groups on Desmin-related myofibrillar myopathy

Patient Handouts on Desmin-related myofibrillar myopathy

Directions to Hospitals Treating Desmin-related myofibrillar myopathy

Risk calculators and risk factors for Desmin-related myofibrillar myopathy

Healthcare Provider Resources

Symptoms of Desmin-related myofibrillar myopathy

Causes & Risk Factors for Desmin-related myofibrillar myopathy

Diagnostic studies for Desmin-related myofibrillar myopathy

Treatment of Desmin-related myofibrillar myopathy

Continuing Medical Education (CME)

CME Programs on Desmin-related myofibrillar myopathy

International

Desmin-related myofibrillar myopathy en Espanol

Desmin-related myofibrillar myopathy en Francais

Business

Desmin-related myofibrillar myopathy in the Marketplace

Patents on Desmin-related myofibrillar myopathy

Experimental / Informatics

List of terms related to Desmin-related myofibrillar myopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Desmin-related myofibrillar myopathy is a subgroup of the myofibrillar myopathy diseases and is the result of a mutation in the gene that codes for desmin which prevents it from forming protein filaments, instead forming aggregates of desmin and other proteins throughout the cell.[1]

Pathophysiology

The sarcomeres become misaligned and result in the disorganization of muscle fibers.[1] This mutation also results in muscle cell death by apoptosis and necrosis.[1] The muscle cell may also be disorganized because the aggregates may interrupt other filament structures and/or normal cellular function.[2]

Desminopathies are very rare diseases and only 60 patients have been diagnosed with so far, however this number probably does not accurately represent the population due to frequent mis or under diagnosis.[2]

Presentation

Common symptoms of the disease are weakness and atrophy in the distal muscles of the lower limbs which progresses to the hands and arms, then to the trunk, neck and face. Respiratory impairment often follows.

Evaluation

AHA Scientific Statement: Management of Cardiac Involvement Associated With Neuromuscular Diseases

Cardiac Evaluation in Myofibrillar Myopathies (MFM)

Class I
"1. Cardiology evaluation with examination, ECG, echocardiogram, and ambulatory electrocardiographic monitoring should take place at the time of MFM diagnosis, regardless of symptoms. (Level of Evidence: C) "
"2. Ambulatory electrocardiographic monitoring or monitoring with a looping event recorder should be performed for assessment of symptomatic palpitations in patients with MFM. (Level of Evidence: C) "
Class IIa
"1. It is reasonable to reassess asymptomatic patients with MFM annually with examination, ECG, and echocardiography. (Level of Evidence: C) "

Inheritance

There are three major types of inheritance for this disease: Autosomal dominant, autosomal recessive and de novo.

  • The most severe form is autosomal recessive and it also has the earliest onset.[2] It usually involves all three muscle tissues and leads to cardiac and respiratory failure as well as intestinal obstruction.[2]
  • Autosomal Dominant inheritance shows a later onset and slower progression. It usually involves only one or two of the muscle tissues.[2]
  • De novo diseases occur when a new mutation arises in the person that was not inherited through either parent. This form has a wide range of symptoms and varies depending on the mutation made.[2]

Treatment

There is currently no cure for the disease but treatments to help the symptoms are available.[2]

References

  1. 1.0 1.1 1.2 Bär H, Strelkov SV, Sjöberg G, Aebi U, Herrmann H (2004). "The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation?". J. Struct. Biol. 148 (2): 137–52. doi:10.1016/j.jsb.2004.04.003. PMID 15477095. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Goldfarb LG, Vicart P, Goebel HH, Dalakas MC (2004). "Desmin myopathy". Brain. 127 (Pt 4): 723–34. doi:10.1093/brain/awh033. PMID 14724127. Unknown parameter |month= ignored (help)

Template:Cytoskeletal defects


Template:Disease-stub